title: [The physician's attitude towards infection by Helicobacter pylori in clinical practice].
abstract: OBJECTIVE
  To study the attitude of general practitioners and internists towards the infection with helicobacter pylori.
  
  
  METHODS
  Interviews were conducted among 170 physicians. Proportions were compared using the Z test.
  
  
  RESULTS
  Out of 170 interviewed, 152 questionnaires were completed correctly: 80.9% were general practitioners and 19% internists. All of the GPs and 84.6% of internists chose the oral-fecal as the route of transmission. Gastric ulcer was thought to be associated by 60.8% of GPs and 72.4% of internists. The least well known association was with MALT lymphoma (8.1%). Biopsy was reported as the best way to make diagnosis (54 and 72.4%). GPs reported they would treat recurring ulcers as Helicobacter pylori, while internists would treat them since the first episode. Sixty point 2 percent (60.2%) of GPs and 69% of internists are using inadequate schemes for treating Hp infections. The combination of omeprazol, amoxicillin, bismuth salts or clarithromycin was the most frequently used.
  
  
  CONCLUSIONS
  Current knowledge regarding Helicobacter pylori infection among GPs and internists is not sufficiently understood.
authors.affiliation: Medico SERUMS.
authors.forename: Pedro Andrés
authors.initials: PA
authors.lastname: Montes Teves
authors.forename: Jaime Ismael
authors.initials: JI
authors.lastname: Soria Medina
authors.forename: Zer Ima
authors.initials: ZI
authors.lastname: Gamarra Espinoza
authors.forename: Eduardo
authors.initials: E
authors.lastname: Monge Salgado
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D001291:Attitude of Health Personnel; D001428:Bacterial Vaccines; D001729:Bismuth / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000209:etiology / Q000382:microbiology; D005664:Furazolidone / Q000627:therapeutic use; D007722:Health Knowledge, Attitudes, Practice; D016481:Helicobacter Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology* / Q000635:transmission; D016480:Helicobacter pylori / Q000276:immunology / Q000302:isolation & purification; D006801:Humans; D007388:Internal Medicine; D018442:Lymphoma, B-Cell, Marginal Zone / Q000382:microbiology; D008875:Middle Aged; D010820:Physicians / Q000523:psychology*; D010821:Physicians, Family / Q000523:psychology*; D011364:Professional Practice; D012008:Recurrence; D013274:Stomach Neoplasms / Q000382:microbiology; D013276:Stomach Ulcer / Q000209:etiology / Q000382:microbiology; D011795:Surveys and Questionnaires
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D005664:Furazolidone; D001729:Bismuth